Skip to content
i2E
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Menu
  • Programs
    • E3
    • ACT Tulsa
    • Love’s Entrepreneur’s Cup
    • OKBio
  • Client Portfolio
  • Services
    • Access to Funding
    • Venture Advisory Services
  • About
    • Our Values
    • Meet Our Team
    • Board of Directors
    • Corporate Partners
  • Contact
  • Media
Search

IMMY On 2015 Inc. 5000 List

Get in Touch

IMMY on 2015 Inc. 5000 list
Copyright © 2015 IMMY

inc5000_num_2823IMMY has been named one of Inc. Magazine’s Fastest Growing Private Companies in America for 2015. Over the past few years, IMMY has recorded revenue growth of 128 percent, with 2014 gross revenue of $6.5M.

The Inc. 5000 list measures revenue growth from 2011 to 2014. To qualify, companies must have been founded and generating revenue by March 31, 2011. Additionally, they had to be U.S.-based, privately held, for profit, and independent (not subsidiaries or divisions of other companies) as of December 31, 2014.

“This is a huge honor for IMMY and all of our amazing employees,” said Dr. Sean Bauman, President and CEO. “To receive an award like this is definitely a credit to the hard work everyone puts in each and every day in carrying out the vision that’s been in place from the beginning: Saving lives one diagnostic at a time.”

IMMY, a diagnostic manufacturing company, has evolved from a company that filled a need in the infectious disease market to an organization with a global focus on saving lives through innovative products. Along with ever-increasing sales in the U.S., the scope of IMMY’s global impact has seen tremendous growth with products going to over 100 different countries.

IMMY’s most successful product to date, the CrAg® LFA, tests for an infection called Cryptococcosis, which kills more than 600,000 people every year. Most of the deaths from this disease are HIV/AIDS patients in Sub-Saharan Africa. Because of the ease-of-use and room temperature storage, the CrAg® LFA is the only rapid test capable of bridging the gap between this disease and the life-saving medicine these patients need.

“Our goal is to save lives,” said Dr. Bauman. “With the CrAg LFA, a health-care provider can give the test, observe the results, and administer the first dose of oral medication, all within a few minutes…resulting in a life that has truly been changed for the better.”

Read the full story at IMMY

Author

  • admin admin

More News

Loading...
woman in lab conducting a study
Blog, i2E
12.13.22

Bayesic Technologies Improves Effectiveness and Efficiency of Data Analysis in Healthcare

Read more
Bison grazing fields
Blog
11.30.22

Bison Underground Merges Nature, Science, and Technology to Tackle Climate Change

Read more
African American family sitting on couch reading and chatting
Blog, E3, i2E
11.22.22

Fokes Connects Families, Caregivers and Care Agencies for Smoother Communications and Care 

Read more
i2e blog post graphic
Blog, News
11.03.22

Introducing: Stories of Oklahoma Innovation

Read more
Default Featured Image
OKBio
06.28.22

Oklahoma Grown! i2E Invests in BIO startups

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma Medical Research Foundation BIO

Read more
Default Featured Image
OKBio
06.13.22

Moleculera Labs BIO

Read more
Default Featured Image
OKBio
06.13.22

University of Oklahoma Health Sciences Center BIO

Read more
Default Featured Image
OKBio
06.13.22

Oklahoma State University BIO

Read more
Default Featured Image
OKBio
06.13.22

ECHO Investment Capital BIO

Read more
Default Featured Image
OKBio
06.13.22

AscendBioVentures BIO

Read more
Default Featured Image
OKBio
06.13.22

Dean McGee Eye Institute BIO

Read more
i2E

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
+1 (405) 235.2305

Tulsa Office

100 S. Cincinnati Ave – Suite 514
Tulsa, OK 74103
+1 (918) 582.5592

  • Client Portfolio
  • About Us
  • Media
  • Events
  • Contact
  • Resources

© 2022 i2E Privacy Policy

Follow us:

Facebook Twitter Linkedin

Programs

  • E3
  • ACT Tulsa
  • Love's Entrepreneur's Cup
  • OKBio
  • Client Portfolio

Services

  • Access to Funding
  • Venture Advisory Services
  • Contact
  • About
  • Our Values
  • Our Team
  • Board of Directors
  • Corporate Partners
  • Media
i2E